Patent landscape of pediatric-friendly oral dosage forms and administration devices

References

• Zajicek A, Fossler MJ, Barrett JS, et al. A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms. Aaps J. 2013;4:1072‐81.
   Google Scholar
• Breitkreutz J, Boos J. Paediatric and geriatric drug delivery. Expert Opinion on Drug Delivery. 2007;4(1):37–45.
   PubMed Web of Science ®Google Scholar
• Piachaud-Moustakis B, Barton CL Pediatric Medicines: global Markets. 2014. [Online]. Available: https://www.bccresearch.com/market-research/pharmaceuticals/pediatric-medicines-markets-report-phm170a.html. [Accessed 2020 05 23]
   Google Scholar
• Barton C, Piachaud-Moustakis B. Pediatric Medicines: global Markets. December 2019. [Online]. Available: https://www.bccresearch.com/market-research/pharmaceuticals/pediatric-medicines-markets-report.html. [Accessed 2020 May 23].
   Google Scholar
• Strickley RG, Iwata Q, Wu S, et al. Pediatric Drugs-A Review of Commercially Available Oral Formulations. . Journal of Pharmaceutical Sciences. 2008;97(5):1731–1774. .
   PubMed Web of Science ®Google Scholar
• Strickley RG. Pediatric Oral Formulations: an Updated Review of Commercially Available Pediatric Oral Formulations Since 2007. J Pharm Sci. 2018;4:1335‐65.
   Google Scholar
• Lopez FL, Ernest TB, Tuleu C, et al. Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms. Expert Opinion on Drug Delivery. 2015;12(11):1727–1740. .
   PubMed Web of Science ®Google Scholar
• Stillhart C, Vučićević K, Augustijns P, et al. Impact of gastrointestinal physiology on drug absorption in special populations--An UNGAP review. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences. 2020;147:147.
   Web of Science ®Google Scholar
• Batchelor HK, Fotaki N, Klein S. Paediatric oral biopharmaceutics: key considerations and current challenges. Adv Drug Deliv Rev. 2014;73:102‐26.
   PubMed Web of Science ®Google Scholar
• Ranmal SR, O’Brien F, Lopez F, et al. Methodologies for assessing the acceptability of oral formulations among children and older adults: a systematic review. Drug Discovery Today. 2018;23(4):830–847. .
   PubMed Web of Science ®Google Scholar
• Mennella JA, Roberts KM, Mathew PS, et al. Children’s perceptions about medicines: individual differences and taste. BMC Pediatrics. 2015;15:15.
   PubMed Web of Science ®Google Scholar
• Martir J, Flanagan T, Mann J, et al. Co-administration of Paediatric Medicines with Food and Drinks in the Context of Their Physicochemical Properties-a Global Perspective on Practices and Recommendations. The AAPS Journal. 2020;22(2):22. .
   PubMed Web of Science ®Google Scholar
• Walsh J, Cram A, Woertz K, et al. Playing hide-and-seek with poorly tasting paediatric medicines: do not forget the excipients. Advanced Drug Delivery Reviews. 2014;73:14‐33.
   PubMed Web of Science ®Google Scholar
• Sohi H, Sultana Y, Khar RK. Taste Masking Technologies in Oral Pharmaceuticals: recent Developments and Approaches. Drug Development and Industrial Pharmacy. 2004;30(5):429–448.
   PubMed Web of Science ®Google Scholar
• Bowles A, Keane J, Ernest T, et al. Specific aspects of gastro-intestinal transit in children for drug delivery design. International Journal of Pharmaceutics. 2010;395(1–2):37‐43. .
   PubMed Web of Science ®Google Scholar
• Reed KA Aqueous drug delivery system. Patent US20200114011A1, 2020.
   Google Scholar
• First S Stable liquid oily ready-to-use formulations, preparation thereof and use thereof. Patent WO2011128783A3, 2011.
   Google Scholar
• Frodsham M, Penton J-A Methotrexate formulation. Patent US20170312281A1, 2017.
   Google Scholar
• Lewerenz C, Schmitz R, Altamura M Pediatric oral liquid compositions containing nepadutant. Patent US9421268B2, 2016.
   Google Scholar
• Polak MB Liquid formulations of hypoglycaemic sulfonamides. Patent US20150051289A1, 2015.
   Google Scholar
• Embrechts R, De Leersnijder C Stabilized pediatric suspension of carisbamate. Patent US10201519B2, 2019.
   Google Scholar
• Jahagirdar HA, Konda KK, Dalal SK, et al. Rifaximin ready-to-use suspension. Patent US20190192490A1, 2019.
   Google Scholar
• Colombo G, Artico R, Mascagni P, et al. Physically and chemically stable oral suspensions of givinostat. Patent US20180311160A1, 2018.
   Google Scholar
• Schwarz FX, Kosilek I Taste-masking pharmaceutical compositions. Patent US7767231B2, 2010.
   Google Scholar
• Guy G, Wright S, Mead A, et al. Use of cannabinoids in the treatment of epilepsy. Patent US20200179303A1, 2020.
   Google Scholar
• Epidiolex (cannabidiol). [Online]. Available: https://www.epidiolex.com/. [Accessed 2020 07 25].
   Google Scholar
• Evans RK, Strable EL, Isopi L Thermally stable rotavirus vaccine formulations and methods of use thereof. Patent US20190000957A1, 2019.
   Google Scholar
• Walser B, Raff HV Peanut formulations and uses thereof. US10653773B2, 2020.
   Google Scholar
• Chinthrajah RS, Cao S, Dunham T, et al. Oral immunotherapy for peanut allergy: the pro argument. World Allergy Organ J. 2020;13(8):100455. .
   PubMed Web of Science ®Google Scholar
• Karavas E, Koutris E, Samara V, et al. Water dispersible mini-tablets comprising enalapril for treatment of hypertension in a pediatric population and method of preparation thereof. Patent US20170202804A1, 2017.
   Google Scholar
• Karanikolopoulos N, Goulding PA Novel pharmaceutical composition. Patent US20200121607A1, 2020.
   Google Scholar
• Elbaz F, Kochhar C, Stingelin D, et al. Pharmaceutical Compositions Comprising Alpelisib. Patent US20190314353A1, 2019.
   Google Scholar
• Fuhrherr R, Lüdemann J, Garrett L Orodispersible tablet containing burlulipase and pharmaceutical composition produced therefrom. Patent US20200009232A1, 2020.
   Google Scholar
• Mirtorabi S Effervescent deferiprone tablet. Patent US20190240144A1, 2019.
   Google Scholar
• オ. フィリップス, ジェフリー, オ. フィリップス and ジェフリー, Novel substituted benzimidazole dosage forms and methods for their use. Patent JP5944943B2, 2016.
   Google Scholar
• Bettman MJ, Hensley DL, Percel PJ, et al. Methylphenidate modified release formulations. Patent WO2002034234A3, 2002.
   Google Scholar
• Potdar A, Momin MS Pharmaceutical composition comprising anticonvulsant with taste mask coating. Patent WO2005020961A1, 2005.
   Google Scholar
• Deschamps B, Ferry A, Vogel A Pediatric formulation. Patent US20180200193A1, 2018.
   Google Scholar
• Karavas E, Koutris E, Samara V, et al. Pediatric powder for oral suspension containing antiviral agent and method for the preparation thereof. Patent WO2016008560A1, 2016.
   Google Scholar
• Decaudin C, Rogue V Oral formulation and suspension of an oncology drug. Patent US20180071305A1, 2018.
   Google Scholar
• Bruijns R Composition as auxiliary means for oral medication. Patent US20190142947A1, 2019.
   Google Scholar
• Bar-Shalom D, Slot L, Fischer G, et al. Swellable dosage form comprising gellan gum. Patent US8383155B2, 2013.
   Google Scholar
• Stanley TH Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics. Patent US4671953A, 1987.
   Google Scholar
• Fuisz CR Rapidly dissoluble medicinal dosage unit and method of manufacture. Patent WO1988008298A1, 1988.
   Google Scholar
• Sádaba B, Azanza JR, García-Bea A, et al. Bioequivalence Evaluation of Three Pediatric Oral Formulations of Bilastine in Healthy Subjects: results from a Randomized, Open Label, Crossover Study. European Journal of Drug Metabolism and Pharmacokinetics. 2020;45(2):265‐72. .
   PubMed Web of Science ®Google Scholar
• Heinig R, Weimann B, Dietrich H, et al. Pharmacokinetics of a new orodispersible tablet formulation of vardenafil: results of three clinical trials. Clinical Drug Investigation. 2011;31(1):27–41. .
   PubMed Web of Science ®Google Scholar
• Van Hecken A, Burckhardt BB, Khalil F, et al. Relative Bioavailability of Enalapril Administered as Orodispersible Minitablets in Healthy Adults. Clinical Pharmacology in Drug Development. 2020;9(2):203–213. .
   PubMed Web of Science ®Google Scholar
• Bajcetic M, de Wildt SN, Dalinghaus M, et al. Orodispersible minitablets of enalapril for use in children with heart failure (LENA): rationale and protocol for a multicentre pharmacokinetic bridging study and follow-up safety study. Contemporary Clinical Trials Communications. 2019;15:15.
   Web of Science ®Google Scholar
• Labeling of Enalapril from Neonates up to Adolescents. 2017. [Online]. Available: https://cordis.europa.eu/project/id/602295. [Accessed 2020 07 26].
   Google Scholar
• Gupta S, Phaldesai SP, Kumar NS, et al. Tofacitinib orally disintegrating tablets. Patent US10034882B2, 2018.
   Google Scholar
• Skulij V, Sirca J, Jenko OM Rapidly disintegrating tablet. Patent WO2004000281A1, 2003.
   Google Scholar
• Ahmed US, Gorukanti RS, Chowdhury AT Ondansetron orally disintegrating tablets. Patent US7390503B1, 2008.
   Google Scholar
• Gosselin AM, Lai J-W, Venkatesh MG Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis. Patent US20200016171A1, 2020.
   Google Scholar
• Herry C, Ailhas C Granules of an active substance with double taste-masking technique, method for the production thereof, and orodispersible tablets containing same. Patent US20190125663A1, 2019.
   Google Scholar
• Venkatesh MG Taste-masked pharmaceutical compositions. Patent US20200146978A1, 2020.
   Google Scholar
• Kurasawa T, Watanabe Y, Omachi Y Orally-disintegrating solid preparation. Patent US9241910B2, 2016.
   Google Scholar
• Oury P, Lamoureux G, Herry C, et al. Multilayer orodispersible tablet. Patent US20040247677A1, 2004.
   Google Scholar
• Shimizu T, Morimoto S, Tabata T Orally disintegrable tablets. Patent US9901546B2, 2018.
   Google Scholar
• Joshi A, Esseku F, Adeyeye CM, Antiretroviral drug formulations for treatment of children exposed to HIV/AIDS. Patent WO2009092002A1, 2009.
   Google Scholar
• Cousin G, Bruna E, Gendrot E Coated granules of allylamine- or benzylamine-anti-mycotics. Patent WO2003009830A1, 2003.
   Google Scholar
• Venkatesh MG, Swaminathan V, Lai J-W et al. Rapidly dispersing granules, orally disintegrating tablets and methods. Patent US20120282335A1, 2012.
   Google Scholar
• Faham A, Marechal D, Chenevier P Orodispersible tablets containing fexofenadine. Patent US20050053654A1, 2005.
   Google Scholar
• Venkatesh MG, Qian KK, Vangala S, et al. Orally disintegrating tablets and methods of manufacture. Patent US9730896B2, 2017.
   Google Scholar
• Fujiwara K, Fukami T, Koizumi H Disintegrating particle composition and orally rapidly disintegrating tablet. Patent US9446055B2, 2016.
   Google Scholar
• Hoarau D Granule and orally disintegrating tablet comprising oxycodone. Patent US8465776B2, 2013.
   Google Scholar
• Sato T, Ota M, Kigoshi M, et al. Orally disintegrating tablet. Patent US9861577B2, 2018.
   Google Scholar
• 洋. 竹. 竹内. Orally disintegrating tablet. Patent WO2010106936A1, 2010.
   Google Scholar
• Ohta M, Kubyama M, Yoshimoto H, et al. Tablets quickly disintegrating in oral cavity. Patent WO2002069933A1, 2002.
   Google Scholar
• FAKM AH, Glad LHC, Hallstein JMC, et al. Orally disintegrating tablets. Patent AU2020201930A1, 2020.
   Google Scholar
• Pebley SW, Jager EN, Thompson JS Improved rapidly disintegrating tablet. Patent WO1994014422A1, 1994.
   Google Scholar
• Cima GL, Cima JM Preparation of medical devices by solid free-form fabrication methods. Patent US5490962A, 1996.
   Google Scholar
• Yoo J, Kumar S, Monkhouse CD Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same. Patent US6471992B1, 2002.
   Google Scholar
• Jacob J, Coyle N, West GT, et al. Rapid Disperse Dosage Form Containing Levetiracetam. Patent US20140271862A1, 2016.
   Google Scholar
• Spritam (levetiracetam). [Online]. Available: https://www.spritam.com/#/patient. [Accessed 2020 07 26].
   Google Scholar
• Jacob J, Caputo K, Guillot M, et al., Rapidly Dispersible Dosage Form with High Drug Content. Patent US20180296479A1, 2018.
   Google Scholar
• 郑易, A kind of Amlodipine Besylate Tablet oral disintegrating tablet prepared using 3D printing and preparation method thereof. Patent CN107823153A, 2018.
   Google Scholar
• 郑易, A kind of preparation method based on ink-jet 3D printing olanzapine orally-disintegrating tablet”. Patent CN110269844A, 2019.
   Google Scholar
• Wang Z Porous dosage compositions and methods of production. Patent US20170202811A1, 2017.
   Google Scholar
• Cochran BD, Dave V, Koll G, et al. Process for making tablet using radiofrequency and lossy coated particles. Patent AU2020201762A1, 2020.
   Google Scholar
• Klingmann V, Pohly CE, Meer T, et al. Acceptability of an orodispersible film compared to syrup in neonates and infants: a randomized controlled trial. European Journal of Pharmaceutics and Biopharmaceutics. 2020;151:239–245.
   PubMed Web of Science ®Google Scholar
• Orlu M, Ranmal SR, Sheng Y, et al. Acceptability of orodispersible films for delivery of medicines to infants and preschool children. Drug Delivery. 2017;24(1):1243‐48.
   PubMed Web of Science ®Google Scholar
• Westrin AB Dexamethasone oral film. Patent US20190175617A1, 2019.
   Google Scholar
• Karavas E, Koutris E, Samara V, et al., Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population. Patent US20170165315A1, 2017.
   Google Scholar
• Schobel MA, Vangala SKSS Solid dosage form containing a taste masked active agent. Patent WO2007109057A3, 2007.
   Google Scholar
• Park J-K, Yang W-S, Jung TK. Quickly soluble oral film dosage containing steviosides as an unpleasant taste masking agent. Patent US9492379B2, 2016.
   Google Scholar
• General S, Terebesi I, Funke A Drug delivery systems (wafer) for pediatric use. Patent WO2011020610A1, 2011.
   Google Scholar
• Yang KR, Fuisz CR, Myers LG, et al. Uniform films for rapid dissolve dosage form incorporating taste-masking compositions. Patent US20190380973A1, 2019.
   Google Scholar
• Steiner D, Kwade A, Structured orodispersible films. Patent US20200108011A1, 2020.
   Google Scholar
• Musazzi UM, Khalid GM, Selmin F, et al. Trends in the production methods of orodispersible films. International Journal of Pharmaceutics. 2020;576:118963.
   PubMed Web of Science ®Google Scholar
• Breitenbach A, Braun S, Schliephacke R, Orodispersible films for the manufacturing of individualized medicine or for large scale production. Patent WO2013023775A1, 2013.
   Google Scholar
• Bernardo J, Gigi V Low moisture rapidly disintegrating oral dissolvable film. Patent US20200016092A1, 2020.
   Google Scholar
• Visser JC, Wibier L, Kiefer O, et al. A Pediatrics Utilization Study in The Netherlands to Identify Active Pharmaceutical Ingredients Suitable for Inkjet Printing on Orodispersible Films. Pharmaceutics. 2020;12(2):164. .
   Web of Science ®Google Scholar
• Laudon M, Zisapel N Melatonin mini-tablets and method of manufacturing the same. Patent US20190060277A1, 2019.
   Google Scholar
• Liang CYA, Dingari V Oral pharmaceutical compositions of mesalazine. Patent US20190105275A1, 2019.
   Google Scholar
• Ayalasomayajula PS, Berkhin M, Bush C, et al. Galenic formulations of organic compounds. Patent AU2019280026A1, 2020.
   Google Scholar
• Desset-Brethes S, Hirsch S Galenic formulations of organic compounds. Patent WO2010086312A1, 2010.
   Google Scholar
• Guittet C, Granier L-A, Maupetit RC Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria. Patent US9636304B2, 2017.
   Google Scholar
• lles R, Becker D, Bonny J-D, et al. Pharmaceutical composition containing terbinafine and use thereof. Patent JP2012136523A, 2012
   Google Scholar
• Dokou E, Jamzad S, Caesar PJ, et al. Pharmaceutical composition and administrations thereof”. Patent US20190274959A1, 2019.
   Google Scholar
• Meesters HMG, Spros FA Composition comprising an antibiotic and a beta-lactamase inhibitor, wherein at| least one of them is in the form of mini-tablets. Patent WO2014033077A1, 2014.
   Google Scholar
• Palmer P, Schreck T, Tzannis S, et al. Small-volume oral transmucosal dosage forms. Patent US20200022918A1, 2020.
   Google Scholar
• Mitra B, Thool P, Meruva S, et al. Decoding the small size challenges of mini-tablets for enhanced dose flexibility and micro-dosing. International Journal of Pharmaceutics. 2020;574:118905.
   PubMed Web of Science ®Google Scholar
• Kluk A, Sznitowska M, Brandt A, et al. Can preschool-aged children swallow several minitablets at a time? Results from a clinical pilot study. International Journal of Pharmaceutics. 2015;485(1–2):1–6. .
   PubMed Web of Science ®Google Scholar
• Thomson SA, Tuleu C, Wong IC, et al. Minitablets: new modality to deliver medicines to preschool-aged children. Pediatrics. 2009;123(2):e235–e238. .
   PubMed Web of Science ®Google Scholar
• Spomer N, Klingmann V, Stoltenberg I, et al. Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study. Archives of Disease in Childhood. 2012;97(3):283–286. .
   PubMed Web of Science ®Google Scholar
• Klingmann V, Linderskamp H, Meer T, et al. Acceptability of Multiple Uncoated Minitablets in Infants and Toddlers: a Randomized Controlled Trial. The Journal of Pediatrics. 2018;201:202‐7.
   PubMed Web of Science ®Google Scholar
• Singh NN Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof. Patent US20170065517A1, 2017.
   Google Scholar
• Thompson KC, Kaighn KN, Mukherjee IN, et al. Taste-Masked Formulations of Raltegravir. Patent US20190167591A1, 2019.
   Google Scholar
• Kashid N, Chouhan P, Mukherji G Chewable bilayer tablet formulation. Patent WO2007144902A8, 2008.
   Google Scholar
• Roche EJ, Reo JP Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets. Patent US5215755A, 1993.
   Google Scholar
• Robinson RL, Damon JR, Mossop JR, et al. Soft chewable tablets. Patent US7029699B2, 2006.
   Google Scholar
• Bunick FJ, Luber J Process for preparing a soft tablet. Patent US6814978B2, 2004.
   Google Scholar
• Tu Y-H, Perumanl A, Kathala K Methylphenidate Extended Release Chewable Tablet. Patent US20200188378A1, 2020.
   Google Scholar
• Karavas E, Koutris E, Samara V, et al. Pediatric chewable tablet containing antiviral agent and method for the preparation thereof. Patent US20170202844A1, 2017.
   Google Scholar
• Dixit MA, Pawar V, Patel R, et al. Abuse deterrent soft chewable drug formulations. Patent US20190000766A1, 2019.
   Google Scholar
• Chavkin L, Mackles L Chewable molded tablet containing medicinally active substances. Patent US5753255A, 1998.
   Google Scholar
• Lee YW Chewable tablet and process for preparation thereof. Patent US6060078A, 2000.
   Google Scholar
• Chow M Enhanced medicinal delivery system processes and products thereby especially useful for children. Patent US9023381B2, 2015.
   Google Scholar
• Romanoschi O, Oryniak C, Muniz LC, et al. Multicomponent gummy compositions with hard core. Patent US20200000716A1, 2020.
   Google Scholar
• Davis J Chewable drug. Patent WO2010151275A1, 2010.
   Google Scholar
• Puglia WJ, Patanasith KJ, Lombardo AT, et al. Compressed chewable antacid tablet and method for forming same. Patent US 4327077A, 1982.
   Google Scholar
• Nguyen NM, Lim LY Taste masking product. Patent US20190350850A1, 2019.
   Google Scholar
• Karavasili C, Gkaragkounis A, Moschakis T, et al. Pediatric-friendly chocolate-based dosage forms for the oral administration of both hydrophilic and lipophilic drugs fabricated with extrusion-based 3D printing. European Journal of Pharmaceutical Sciences. 2020;147:105291.
   PubMed Web of Science ®Google Scholar
• Goyanes A, Madla CM, Umerji A, et al. Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: first single-centre, prospective, crossover study in patients. International Journal of Pharmaceutics. 2019;567:118497.
   PubMed Web of Science ®Google Scholar
• Cardon C Pharmaceutical formulation administratable orally in terms of a taste, consistency and a dosing. WO2006072872A1, 2006.
   Google Scholar
• Radke J, Jones M, Erickson M Palatable suspending vehicle for pharmaceutical ingredients. US8986729B2, 2013.
   Google Scholar
• Maibach T Methods for oral administration of active drugs. US20090155363A1, 2007.
   Google Scholar
• Mcgurk SL, Czekai DA Gel-stabilized nanoparticulate active agent compositions. WO2005000265A2, 2003.
   Google Scholar
• Westhusing MT, Bai Y, Medri MW Semi-solid chewable dosage form for over-the-counter medications and method for producing same. Patent US20170209370A1, 2017.
   Google Scholar
• Cherukuri SR Rapid-melt semi-solid compositions, methods of making same and methods of using same. Patent US6589556B2, 2001.
   Google Scholar
• [真健 大樂一毅 岡本仁 松瀬. Levetiracetam-containing gel oral pharmaceutical composition. WO2018230329A1, 2018.
   Google Scholar
• Fukui A Bitterness-masking particulate jelly beverage. US8287897B2, 2007.
   Google Scholar
• Walsh J, Bickmann D, Breitkreutz J, et al., European Paediatric Formulation Initiative (EuPFI). Delivery devices for the administration of paediatric formulations: overview of current practice, challenges and recent developments. International Journal of Pharmaceutics. 415(1–2): 221–231. 2011.
   PubMed Web of Science ®Google Scholar
• Clements D An apparatus for weight based single doses of medication. Patent WO2015195148A1, 2015.
   Google Scholar
• Creaturo MA Safety syringe and safety dose combination kit. Patent US20180264197A1, 2018.
   Google Scholar
• Barrelle L, Perot F, Felix-Faure C Device for oral administration of a medicine. Patent US8016795B2, 2011.
   Google Scholar
• Fuchs K-H Dosing pipette. Patent US9919306B2, 2018.
   Google Scholar
• Gargione FV, Buehler JD, Holding T Child friendly syringe. Patent WO2002085429A2, 2004.
   Google Scholar
• Tavares AM Baby bottle coupled to medicament-dispensing syringe. Patent WO2011057366A1, 2011.
   Google Scholar
• Burchett MT, Burchett LW Nursing bottle with medication dispenser. Patent WO1994026325A1, 1994.
   Google Scholar
• Vieira de Oliveira M. Medicine delivery nurser. Patent WO2015057892A1, 2015.
   Google Scholar
• Ii RB O, Brock BP, Spivey CJ, et al. Apparatus and methods for oral administration of fluids and medical instrumentation. Patent WO2015061749A1, 2015.
   Google Scholar
• McNac HI, McNac HJ Medicated and Flavored Pacifier. Patent US20130085475A1, 2013.
   Google Scholar
• Ashton WS Method and apparatus for oral hydration and medication administration using a pacifier apparatus. Patent US6454788B1, 2002.
   Google Scholar
• Evans S, Tasber F Dosing spoon. Patent US8683705B2, 2014.
   Google Scholar
• 李巧秀, A kind of novel children medicine-feeding device. Patent CN207855962U, 2018.
   Google Scholar
• Malkin J, Addeo GJ Method of manufacturing pediatric medicine dosage cup. Patent US20120251702A1, 2012.
   Google Scholar
• Manning CE Medication delivery straw. Patent US5718681A, 1988.
   Google Scholar
• Gelfand D. Drinking Straw. Patent US20070262164A1, 2007.
   Google Scholar
• Schwarz FX, Jakob T, Reichenberger R Device for the oral application of a substance. Patent US9375108B2, 2016.
   Google Scholar
• Flynn AD, Galgon GM, Gerrard SE, et al. Devices for delivering an agent into breastmilk and associated systems and methods. Patent US20190060180A1, 2019.
   Google Scholar
• Hart CW, Israel-Ballard KA, Joanis CL, et al. Acceptability of a Nipple Shield Delivery System Administering Antiviral Agents to Prevent Mother-to-Child Transmission of HIV through Breastfeeding. Journal of Human Lactation. 2015;31(1):68–75. .
   PubMed Web of Science ®Google Scholar
• Manzone C, Colussi M Drug storage and delivery system containing a medicated lollipop. Patent US6159492A, 2000.
   Google Scholar
• Schwarz FX, Szerdi S Method and device for oral application of a composition. Patent WO2010081867A1, 2010.
   Google Scholar
• Medical B & Co KG GmbH. Device for metering and dispensing of material. Patent DE202017106367U1, 2017.
   Google Scholar
• Berenshteyn A, Gotliboym M, Granelli C Dosing device for measuring and dispensing mini-tablets. Patent US20200054530A1, 2020.
   Google Scholar
• Reinhold TS, Felsner C Dispensing device for solid portions and method for dispensing solid portions. Patent US10099841B2, 2018.
   Google Scholar
• Reinhold TS, Sawitzki P Device and method for singularized dispensing of solid portions. Patent US9815611B2, 2017.
   Google Scholar
• Tzannis S, Hamel L, Palmer P, et al. Bioadhesive drug formulations for oral transmucosal delivery. Patent US8865211B2, 2014.
   Google Scholar
• Poutiatine AI, Rampersaud C, Edwards B, et al. Storage and dispensing devices for administration of oral transmucosal dosage forms. Patent US9066847B2, 2015.
   Google Scholar
• Muller RB, Fleming K Multi-size pill splitter and methods. Patent EP3119376B1, 2020.
   Google Scholar
• Sundt PC Multiple pill or tablet splitter. Patent US9827165B1, 2017.
   Google Scholar
• Evans A. Pill Crusher. Patent US20190201291A1, 2019.
   Google Scholar
• Scott J. A child friendly compact asthma inhaler kit. Patent GB2484836A, 2012.
   Google Scholar
• Malone R Pediatric inhalation device. Patent US20020104531A1, 2002.
   Google Scholar
• Poree T Inhalation device for young child or infant. Patent FR3077736A1, 2019.
   Google Scholar
• Mistry J, Sixsmith E Apparatus for use in delivering respiratory drugs. Patent WO2019237151A1, 2019.
   Google Scholar
• Amirav I, Halamish A, Newhouse M, et al. Mask for administration of inhaled medication. Patent US10675420B2, 2020.
   Google Scholar
• Shahaf D Means and method for administering medicaments to infants. Patent US20130118485A1, 2013.
   Google Scholar
• FDA, Guidance for Industry. E11 Clinical Investigation of Medicinal Products in the Pediatric Population, December 2000 . [Online]. Available: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e11-clinical-investigation-medicinal-products-pediatric-population. [Accessed 2020 Sept 6].
   Google Scholar
• WHO, Efforts on child-appropriate medicines intensify, 6 December 2007. [Online]. Available: https://www.who.int/mediacentre/news/releases/2007/pr63/en/. [Accessed 2020 Sept 6].
   Google Scholar
• EMA, Paediatric investigation plans, [Online]. Available: https://www.ema.europa.eu/en/human-regulatory/research-development/paediatric-medicines/paediatric-investigation-plans. [Accessed 2020 Sept 6].
   Google Scholar
• FDA, Pediatric Study Plans: content of and Process for Submitting Initial Pediatric Study Plans and Amended Initial Pediatric Study Plans Guidance for Industry, July 2020. [Online]. Available: https://www.fda.gov/media/86340/download. [Accessed 2020 Sept 6].
   Google Scholar
• Van Riet-Nales DA, Kozarewicz P, Aylward B, et al. Paediatric Drug Development and Formulation Design—a European Perspective. AAPS Pharm Sci Tech. 2017;18(2):241–249.
   PubMed Web of Science ®Google Scholar
• Varnai P, Farla K, Simmonds P, et al. Study on the economic impact of the Paediatric Regulation, including its rewards and incentives. December 2016. [Online]. Available: https://ec.europa.eu/health/sites/health/files/files/paediatrics/docs/paediatrics_10_years_economic_study.pdf. [Accessed 2020 07 26.
   Google Scholar
• Penkov D, Tomasi P, Eichler I, et al. Pediatric Medicine Development: an Overview and Comparison of Regulatory Processes in the European Union and United States. Therapeutic Innovation & Regulatory Science. 2017;51(3):360–371.
   PubMed Web of Science ®Google Scholar
• Cooper KJ. Pediatric marketing exclusivity--as altered by the Best Pharmaceuticals for Children Act of 2002. Food Drug Law J. 2002;57:519–544.
   PubMed Web of Science ®Google Scholar
• Turner MA, Catapano M, Hirschfeld S, et al. Global Research in Paediatrics. Paediatric drug development: the impact of evolving regulations. Advanced Drug Delivery Reviews. 2014;73:2‐13.
   Web of Science ®Google Scholar
• Tsukamoto K, Carroll KA, Onishi T, et al. Improvement of Pediatric Drug Development: regulatory and Practical Frameworks. Clinical Therapeutics. 2016;38(3):574‐81.
   PubMed Web of Science ®Google Scholar
• European Union Pediatric Formulations Initiative. [Online]. Available: http://eupfi.org/STEP%20Database/STEP%20database%20-FAQs.pdf [Accessed 2021 Jan 25].
   Google Scholar
• EMA, Guideline on pharmaceutical development of medicines for paediatric use, 2013. [Online] Available: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-pharmaceutical-development-medicines-paediatric-use_en.pdf. [Accessed 2021 Jan 17].
   Google Scholar
• Kozarewicz P. Preservatives: are they safe? 2010. [Online] Available: www.ema.europa.eu/docs/en_GB/document_library/Presentation/2010/09/WC500096784.pdf. [Accessed on 2021 Jan 17].
   Google Scholar
• De Luca C. Medicine patent pool – pharma philanthropy or PR?. Expert Opin Thera Pat. 2015;25:1223-27.
   Google Scholar